A study comparing ways to assess breast cancer risk (CanRisk-ClinGen)
This study is looking at a pathway using the CanRisk assessment tool to assess breast cancer risk. The team are comparing this pathway to the usual pathway
This study is looking at a pathway using the CanRisk assessment tool to assess breast cancer risk. The team are comparing this pathway to the usual pathway
This trial is looking at a new drug called camizestrant for early breast cancer that has a medium to high risk of coming back.
This trial is looking at aspirin by itself and in combination with metformin as well as the food supplement called resveratrol to prevent bowel polyps.
This trial is comparing new combinations of treatment with standard treatment for follicular lymphoma.
This trial is comparing stereotactic body radiotherapy to the prostate with stereotactic body radiotherapy to the prostate and lymph nodes in the pelvis.
This trial is looking at a targeted cancer drug called sacituzumab govitecan in combination with the immunotherapy drug pembrolizumab.
This study is looking at an app to provide an individual exercise and diet programme to prepare for lung cancer surgery.
This study is looking at blood and urine samples to try to pick up liver cancer earlier.